results to age. The low power (.24) displays the need for larger sample sizes which could be obtained by using multicenter data sites. Future research with national collaboration and standard performance measurement systems could provide crucial information related to hepatitis B immunity in health care workers.
H epatitis B viral infection is a major occupational risk for nurses. In addition, other workers employed in hospitals, health related settings, and public sector jobs are exposed to this viral illness. The Centers for Disease Control and Prevention (CDC) estimates approximately 12,000 workers become infected each year from hepatitis B exposures (Kane, 1989) . This number has been corrected for subclinical cases and underreporting. Increased vaccine usage and other factors have decreased rates of hepatitis B from 11.5% in 1985 to 6.32% in 1992 (rate per 100,000 population) (CDC, 1992) . However, the incidence of 140,000 to 320,000 infections per year in the United States continues, with an estimated 5,000 to 6,000 deaths per year from chronic liver disease including primary liver cancer. Also, there are an estimated 1 to 1.25 million chronically infected Americans (CDC, 1992) . The estimated incidence of hepatitis B in 1998 was 22.5 cases per 100,000 population (CDC 2000) . Health care workers provide care for this same population, placing them at risk from occupational exposure. Occupational health nurses need to be knowledgeable about this illness to provide appropriate care for these workers.
Definitions
• High risk health care workers are hospital employees working in the following areas: emergency department, intensive care departments (intensive care unit or coronary care unit), laboratory, operating room, respiratory care, or radiology.
• Arm is the 1M injection given in the deltoid muscle.
• Hip is the 1M injection given in the gluteal muscles, or buttocks.
• Hepatitis B immunity is a positive hepatitis B antibody titer.
• Seven years post vaccination in this study is defined as the date of the first hepatitis B vaccine to the present date. Thus, it is possible for some health care workers to be 6% years post total vaccination series and be included in this study. This includes those greater than 7 years post vaccination.
• Nonreactive means the health care worker did not develop antibodies to hepatitis B vaccine after the first series.
• Nonresponders are health care workers who are nonreactive to the hepatitis B vaccine after two complete series of vaccines are given.
While much is known about hepatitis B virus (HBV), several areas of knowledge are not known or not substantiated by research. Immunity is defined as the development of hepatitis B antibodies at a serum concentration level of greater than 10 lUlL (West, 1996) . (See the Sidebar on page 326 for definitions of other terms used in this article.) Immunity level of the hepatitis B antibodies can decrease over time with age, but it is not known by how much or if the decrease is significant for clinical protection (Bennett, 1996; West, 1996) . West (1996) found the level of antibodies for hepatitis B surface antigens did decrease over time after vaccination. This decrease was rapid the first year and slower in each year after initial vaccination. West (1996) reviewed 10 studies of healthy participants and 13 studies of healthy participants in settings that gave them an increased risk of exposure to hepatitis B. The results varied widely. In one study of New Zealand adolescents (n =71), after 5.5 years 90% retained immunity. In another study of homosexual males (n = 634), after 7 to 9 years, only 46% retained immunity. The latter group exposed to hepatitis B had low rates (2.8%) of seroconversions for hepatitis B infections. However, the sample sizes of the review cases are small, with the largest approximately 1,500.
In addition, a significant number of health care workers do not show signs of seroconversion after the vaccine 326 series. Some studies show this group of nonresponders to be as high as 5% to 10% (Zuckerman, 1997) . A nonresponder is a health care worker who has received two complete series of vaccine, but still does not develop antibodies. Zuckerman (1997) reported nonresponders remain susceptible to HBV infection. She believed nonresponsiveness is due to a specific component of the hepatitis B surface antigen, and is testing a new vaccine specifically for these nonresponders. She reported a rate of 5% to 10% of nonresponders in healthy immunocompetent participants. Zuckerman related several factors decrease the antibody response to hepatitis vaccination, including site and route of injection, sex, obesity, advancing age, and immunosuppression.
Occupational health nurses need research data to make decisions about providing protection to high risk health care workers in a cost effective manner. This study begins to explore these issues by describing HBV immunity in high risk health care workers 7 years post immunization.
LITERATURE REVIEW
The HBV is a hepadnavirus with 42 nm, partially double stranded DNA virus (Benenson, 1995) . Chronic HBV infection is found in .5% of adults in North America. The HBV often causes a subclinical infection. In moderate cases one experiences fatigue, anorexia, vomiting, headache, and low grade fever. In the icteric phase jaundice appears and liver destruction occurs. In the recovery phase, the liver function tests return to normal although the infection may last from 8 or 12 weeks or more (McCance, 1994) . Fifteen percent to 20% of individuals with chronic HBV infection will die early of cirrhosis or liver cancer. In fact, HBV infection can predispose one to cancer; it (HBV) is the cause of as much as 80% of hepatocellular carcinoma cases (Benenson, 1995) .
Hepatitis B virus is common in certain high risk groups, including intravenous drug users and individuals with multiple sex partners. Employees in special health care occupations at high risk include those working in the emergency departments, operating rooms, dental offices, and laboratories. These high risk health care workers are at risk by percutaneous and permucosal exposure to blood or body fluids. A health care worker risks a 6% to 30% chance to contract HBV after a percutaneous exposure (CDC, 1991) . A percutaneous exposure is a puncture in the skin by a sharp, contaminated object, such as a needlestick. In comparison, the risk of contracting HIV from a similar exposure is less than .3%. While most health care workers fear HIV infection, they are often uninformed about the higher risk of hepatitis B. In fact, approximately 200 to 300 deaths occur yearly because of HBV infection (Rapoza, 1989) .
To understand the impact on the occupational nurse, it is necessary to understand the history of HBY. The HBV vaccine was first licensed in 1982 (Saxe, 1996) . Originally, it was manufactured from the plasma of chronic hepatitis B virus carriers (Zuckerman, 1997) . In 1987, a vaccine prepared by recombinant DNA technology, grown in yeast cells, became available (Mundt, 1992) . Some feared, incorrectly, the use of donor plasma in the first vaccine because they thought HIV infection could be in the vaccine. The present DNA engineered vaccine is well received and considered very safe. In 1982, the CDC issued recommendations for protecting health care workers against HBV infections, and in 1992, the Occupational Safety and Health Administration (OSHA) standards became effective. Among other mandates, OSHA required employers to offer the HBV vaccine free to at risk workers (Ramsey, 1996) .
Because these 1992 mandates offer a safe and free vaccine, subsequent studies have been conducted to investigate their effects. According to Ramsey (1996) , a 34% increase in the HBV vaccination rate occurred between 1991 and 1993. This study found only 4.1% of exposures were reported. Body fluid splashes (permucosal) were the most common type of exposure (81%), but the least likely to be reported.
Likewise, another study considered the impact of the new standards on HBV vaccination on health care workers (Agerton, 1995) . This study was a survey related to hepatitis B vaccination of hospital employees. Of the 96 hospitals responding, 50% conducted routine post-vaccination serologic testing on all employees to confirm immunity. The findings indicated testing should be considered for health care workers at high risk for exposure to blood, such as nurses and phlebotomists. This has since become a recommendation of the Advisory Committee on Immunization Practices (ACIP) (Agerton, 1995) . The authors believed testing all employees, including clerical, dietary, and maintenance workers, was not cost effective and was unnecessary. The authors did not discuss the other 50% of the hospitals that did not test all workers, or whether these hospitals consistently tested high risk workers.
Moreover, this study reported that after the standard was implemented, approximately one fourth of the program managers reported inadequate program staff for administering hepatitis B vaccine to all eligible employees (Agerton, 1995) . The survey was conducted from May through June 1992. Since 1992, many hospitals have experienced staffing cuts because of managed care environments. It is not known if these cuts have been in occupational health services staffing or if decreased funding has impacted occupational health care services for health care workers.
Agerton (1995) also found 15% of the hospitals routinely administered hepatitis B vaccine booster doses to all employees every 3, 5, or 7 years. According to the author, the ACIP does not recommend booster doses following routine vaccination. A pattern of confusion concerning both the post-vaccination testing and repeat booster is evident.
This confusion comes from a gap in knowledge. The ACIP of the U.S. Public Health Service recommends serologic testing be considered for high risk health care workers (Agerton, 1995) . Although the ACIP does not recommend booster doses following routine hepatitis B vaccination (Agerton, 1995) , one of the vaccine manufacturers states, "the duration of the protective effect of JULY 2000, VOL. 48, NO.7 vaccine in healthy vaccinees is unknown at present and the need for booster dose is not yet defined" (Merck, 1996) . However, studies have shown that the site and route of injection, the sex and age of the recipient, obesity, ethnicity, and the immunosuppression status of the recipient may cause decreased response or no response to the vaccine (West, 1996; Zuckerman, 1997 ).
Zuckerman's study (1997) , conducted in Great Britain, also points to evidence that shows specific low responsiveness in different injection sites. Specifically, approximately 70% of nonresponder health care workers seroconverted with a single dose of a new triple S recombinant hepatitis B vaccine, which is in the experimental testing phase. Zuckerman (1997) reported the preferred site of injection is the deltoid muscle. Injections administered in the buttocks are not as effective because "fat lacks antigen presenting cells, resulting in a delay presentation of antigen T and B cells." Many health care workers received the HBV in the buttocks, a site which studies later indicated was less effective because the vaccine was not absorbed well in the fatty tissue.
In addition to injection site, age (Zuckerman, 1997 ) also may influence vaccine effectiveness. Health care workers are aging along with other members of the general population. The average age of nurses is now 44, according to a 1996 survey by the Health Resources and Services Administration (Zurlinden, 1998) . Thus, the current descriptive study sought to describe the immunity from HBV vaccine in high risk health care workers 7 years or greater post vaccination. It seeks to fill gaps in knowledge to facilitate research based decisions about rebooster and post-vaccination testing.
PURPOSE
The study was a descriptive, quantitative study focusing on hepatitis B immunity in high risk health care workers. The following questions were posed: • Does immunity decrease with age? (Note that in this descriptive study, the titer was assessed 7 years or greater post vaccination.) • Does immunity decrease with site of injection? • What is the rate of nonreactives in this population?
METHODS
This study was a review of laboratory values and health information from Employee Health Services of a 295 bed, urban hospital in a large metropolitan area. Some data were available through review of employee health records. Other information was obtained through interviews with health care workers. Some workers had to obtain their health care records from other sources (i.e., prior employers or family physician). Some employees had never been tested to know if they were immune. They had no baseline titer post-vaccination series. If the employee gave consent, phlebotomy was performed to obtain blood for titer testing, according to this hospital's occupational health guidelines. All participants provided written consent to participate in the study. This written consent was required by the sponsor- 
Data Analysis
The data were analyzed according to standard statistical methods. Three measures of data were collected: results of hepatitis B titer, age, and site of injection.
Sample
The target participants were a convenience sample from the high risk clinical areas of the emergency department, radiology, operating room, respiratory therapy, intensive care units (lCU and CCU), and laboratory. In each of these areas workers are exposed to blood in their daily duties. Workers were individually given information about the study and asked to participate . If they met criteria their results were included in the study. Occupational health guidelines were followed for all employees. No consequences occurred if workers chose not to participate.
Procedures
Hospital laboratory staff performed hepatitis titers. A level of 10 lUlL or greater was assumed to be positive . The titers were processed in batches for a relatively inexpensive cost , approximately $2 or $3 per test.
ASSUMPTIONS
This study described a specific population. Whether this population represents other national health care worker groups is unknown. A positive, or reactive, hepatitis B titer was assumed to be at least 10 lUlL. The level of 10 lUlL is assumed to be positive seroconversion 328 (Zuckerman, 1997) . This level has been cited as a standard by the ACIP and the World Health Organization (West, 1996) . Therefore, a positive, or reactive, hepatitis B surface antibody titer was an assumed seroconversion.
RESULTS
This descriptive study of a convenience sample (n = 42) found 21% of health care workers had nonreactive titers 7 years or greater post immunization. The mean age of the sample was 41. Only 9.5% received at least one injection in the hip. Even though each worker had to be at least 7 years post immunization to be included in the study, different lengths of time from vaccine to titer were common. The mean length of time from vaccine to titer was 8.7 years, with a maximum of 15 years (see Table 1 ).
A two by two chi square analysis of the relationship of injection site to titer was conducted (X 2 = .07, df = I, P =.79). Table 2 shows 80% of the sample population tested positive. Thus, no significant differences existed in the percentages of the reactive participants according to injection site (arm = 81%, hip = 75%). A two tailed t test was performed comparing titer results by age. Although the two groups' average ages were more than 4 years apart, no statistically significant relationship was revealed (see Table 3 ).
DISCUSSION
Occupational health nurses can be key players in teaching health care workers about the risks of HBV by promoting and administering the series of three vaccines. These same nurses should set up protocols within their institutions to address the care of their health care workers over time, considering their age, possible changes in their immunity post-vaccination, and the care of employees who never seroconvert. The occupational health nurse can have significant impact in promoting quality of care and the most efficient use of funds related to HBV immunity in health care workers. Thus, research based practice is imperative.
In this study, the rate of nonreactives is high (21%), compared to previous recorded rates of nonresponders (5% to 10%) (Zuckerman, 1997) . This high rate of nonreactive individuals is significant. If employees who are nonreactive have an exposure to blood or body fluids, they may receive late or incomplete treatment. All nonreactives in the study were counseled to receive a second series and a repeat titer. Because there was no control group, it is not known whether the current nonreactives have always been lacking antibodies, or whether their immunity decreased with time. An experimental study, in which the design called for the participants to have a baseline titer, followed by a repeat titer in 7 years, is recommended.
While previous studies have shown otherwise, the data in the current study did not show any significant differences according to injection site and conversion rates. However, Merck (1996) now recommends hepatitis B vaccine be administered in the arm (deltoid muscle).
The titer level was treated as dichotomous data, reactive or nonreactive, versus a continuous data or exact level. Dichotomous values were used for two reasons. One is that 10 lUlL or greater is internationally recognized as a positive level; having a higher level does not necessarily confer greater immunity (Zuckerman, 1997) . Second, dichotomous testing is less costly than performing exact titer levels. A negative outcome using this type of data is continuous values may have increased the power of the study, leading to more specific correlations.
No relationship was found comparing age and titer. Nevertheless, power for this sample size was a low .24. To possibly obtain significant results, a power of .8 would require a sample of 70 in each group (likewise, for .70 power, n =55.) To obtain a sample of70 nonreactive health care workers, assuming a 10% to 20% rate of nonreactives in this population, a researcher needs to test approximately 700 to 1,400 health care workers. Thus, obtaining appropriate power may be difficult for one institution to accomplish. If occupational nurses are to provide care and set standards for hepatitis B immunity concerning health care workers, a move towards multiple site data collection is required. A uniform data set is needed.
The occupational health of health care workers is important. This study, while small in its sample size, points to the lack of knowledge, standardization, and funding in this crucial area. The authors found reference to inadequate staffing which negatively impacted hepatitis B vaccinations for high risk health care workers JULY 2000, VOL. 48. NO.7 
Proposed Basic Standards
• Hepatitis B surface antibody titer testing 8 weeks after the initial vaccine series for high risk health care workers.
• Hepatitis B surface antibody titer testing every 5 years for high risk health care workers.
• JCAHO standards for the function of occupational health services, including performance measurement systems recommendations. Hepatitis B immunity would be a measurement.
(Agerton, 1995). The current study points out the need for multicenter data sites to obtain statistically effective results . While it may appear to be premature based on the information provided, the authors strongly recommend Joint Commission on Accreditation of Healthcare Organizations (JCAHO) standards for the function of occupational health services for all health care facilities. In fact, in 1998 JCAHO met with other organizations "to discuss possible standards related directly to employee health issues" (Rissman, 1998) . These standards would ensure funding of programs, including support for research based on continuous quality improvements. According to JCAHO's website (http://www.jcaho .org):
Their quality initiative, introduced February 1997, integrates outcomes and other performance measurement data into the accreditation process. It is intended to be an approach for supporting quality improvement efforts in accredited organizations and for increasing the value of accreditation . Organizations will be expected to demonstrate, for each measure, the ability to collect data reliably, conduct credible analysis of the data, and initiate appropriate system and process improvements.
Each hospital is expected to choose specific quality measures, which are tracked for process improvements. If hepatitis B immunity was approved as a measure, nationally based data and improvements could be obtained.
The JCAHO, working with partners such as OSHA, CDC, ACIP, and private businesses could ensure basic standards for hospital employees (see Sidebar on this page). Without these standards, the occupational health of health care workers is well intentioned, but never fully realized or funded.
CONCLUSION
Hepatitis B remains a significant occupational risk for health care workers. Researched based practice and protocol can and must guide occupational health providers. National collaboration and performance
What Does This Mean for Workplace Application?
Hepatitis B viral infection is a major occupational risk for health care workers; this infection can lead to disability, chronic liver disease, and liver cancer. A health care worker risks a 6% to 30% chance of contracting hepatitis B viral infection after a percutaneous exposure. The duration of immunity after immunization with the hepatitis B vaccine series is unknown. This descriptive study found 21% of health care workers had nonreactive titers 7 years or greater post immunization. The mean age of the sample was 41. Larger study groups at multicenter sites are needed for statistically effective results. The authors recommend JCAHO standards for the function of occupational health services, which would provide funding and resources for research based practice improvements.
measurement systems could provide crucial information related to hepatitis B and other occupational hazards related to health care workers. As hepatitis C and other types of related viruses are discovered, ongoing research on the hepatitis B virus will provide an important foundation of protection for health care workers in the future.
